REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmix D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmix D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Farmix D.O.O. Beograd is a pharmaceutical company specializing in sales, marketing, and regulatory business in the field of medicines and medical devices. With long-year experience in representing foreign firms, Farmix is recognized for its interactive cooperation with a multinational company specializing in high-quality Blood derivatives. The company's activities include the import and distribution of drugs and medical products within the framework of the establishment of the health system in Serbia.

Headquarters
Koce Kapetana 36
Belgrade; Belgrade; Postal Code: www.farmix.rs

Contact Details: Purchase the Farmix D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Farmix D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Farmix D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Farmix D.O.O. Beograd report to view the information.
Incorporation Date:
December 20, 1991
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Farmix D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
7.43%
Total operating revenue
7.38%
Operating profit (EBIT)
634.83%
EBITDA
205.35%
Net Profit (Loss) for the Period
170.4%
Total assets
2.1%
Total equity
11.84%
Operating Profit Margin (ROS)
2.73%
Net Profit Margin
6.92%
Return on Equity (ROE)
6.3%
Quick Ratio
0.92%
Cash Ratio
1.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?